Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents (vol 79, pg 2943, 2024)

被引：0
|
作者：
Jackson, D. J.
Wechsler, M. E.
Brusselle, G.
Buhl, R.
机构：
来源：
ALLERGY | 2025年
关键词：
D O I：
10.1111/all.16541
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Increased high molecular weight IL-5 complex after anti-IL-5 (Mepolizumab) therapy
    Stein, M. L.
    Munitz, A.
    Rothenberg, M. E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S118 - S118
  • [32] Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
    Gevaert, Philippe
    Lang-Loidolt, Doris
    Lackner, Andreas
    Stammberger, Heinz
    Staudinger, Heribert
    Van Zele, Thibaut
    Holtappels, Gabriele
    Tavernier, Jan
    van Cauwenberge, Paul
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (05) : 1133 - 1141
  • [33] Exacerbations of Severe Asthma While on Anti-IL-5 Biologics
    Bhalla, A.
    Zhao, N.
    Rivas, D. D.
    Ho, T.
    de Liano, Perez L.
    Mukherjee, M.
    Nair, P.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (05) : 307 - 316
  • [34] Anti-IL-5 in pediatric allergic diseases
    Tenero, Laura
    Arturi, Elisa
    Piazza, Michele
    Piacentini, Giorgio
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 : 14 - 16
  • [35] CRSwNP: Anti-IL-5 Therapy as a Gamechanger
    Fessler, Beate
    ALLERGO JOURNAL, 2022, 31 (01) : 52 - 52
  • [36] Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update
    Walsh, Garry M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (10) : 1237 - 1243
  • [37] Anti-IL-5 in the treatment of nasal polyps
    Kowalski, Marek L.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2007, 7 (03) : 195 - 196
  • [38] Vasospasm due to eosinophilic coronary periarteritis treated with an anti-IL-5
    De Los Rios Ospina, L. M.
    Dalmau Duch, G.
    Bardaji Ruiz, A.
    Gazquez Garcia, V
    Esteso Hontoria, O.
    Gaig Jane, P.
    ALLERGY, 2021, 76 : 169 - 170
  • [39] Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series
    Tashiro, Hiroki
    Takahashi, Koichiro
    Kurihara, Yuki
    Sadamatsu, Hironori
    Kuwahara, Yuki
    Kimura, Shinya
    Sueoka-Aragane, Naoko
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 169 - 177
  • [40] Correction to: A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Haruki Koike
    Ryoji Nishi
    Satoru Yagi
    Soma Furukawa
    Yuki Fukami
    Masahiro Iijima
    Masahisa Katsuno
    Advances in Therapy, 2023, 40 : 718 - 718
12345